Evidence map›Paper›PMID 42267195›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2026

TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells.

Giulia Ambrosini, Elisa Dalla Pozza, Ilaria Cristanini, Sara Vinco, Enrica Cappellozza, Barbara Cisterna, Claudio Laquatra, Andrea Rasola, Emanuela Bottani, Ilaria Dando

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giulia AmbrosiniDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.
Elisa Dalla PozzaDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.
Ilaria CristaniniDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.
Sara VincoDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.
Enrica CappellozzaDepartment of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.
Barbara CisternaDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.
Claudio LaquatraDepartment of Biomedical Sciences, University of Padova, Padova 35131, Italy.
Andrea RasolaDepartment of Biomedical Sciences, University of Padova, Padova 35131, Italy.
Emanuela BottaniDepartment of Diagnostics and Public Health, University of Verona, Verona 37134, Italy.
Ilaria DandoDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer stem cellsCDH1mitochondriaoxidative phosphorylationpancreatic ductal adenocarcinomaTRAP1

Identifiers

PMID42267195
PMCPMC13244268

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.